Google AI


Modern Australian

GLP-1 drugs like Ozempic may lower the risk of addiction: new study

  • Written by: Shalini Arunogiri, Addiction Psychiatrist, Associate Professor, Monash University
GLP-1 drugs like Ozempic may lower the risk of addiction: new study

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows.

Semaglutide (also known as Ozempic), liraglutide and tirzepatide (Wegovy) belong to a class of drugs called GLP-1 (glucagon-like peptide-1) receptor agonists. These mimic a hormone involved in regulating blood sugar and appetite.

Interest in GLP-1s for addiction has grown in the past decade, as some people prescribed them for diabetes or weight loss noticed they were drinking less alcohol or smoking less.

Animal studies suggested these drugs might reduce cravings and lower the risk of relapse. Large studies using health records or administrative data hinted at similar patterns.

This new study, published today in the BMJ, found starting a GLP-1 drug was linked with a 14% overall reduced risk of developing new substance use disorders, including alcohol, cannabis, cocaine, nicotine and opioids. Among people with an existing substance use disorder, taking a GLP-1 was associated with a 26% reduction in substance-related hospital admissions.

What did the researchers do?

Researchers examined electronic health records from more than 600,000 veterans with diabetes who were treated through the United States Department of Veterans Affairs.

Researchers compared those newly prescribed a GLP-1 with those started on a different class of diabetes medication called SGLT2 inhibitors (including empagliflozin and dapagliflozin) – a well-established treatment used as a comparison point.

The study followed participants for up to three years, asking two questions:

  • among people with no prior addiction diagnosis, were those on GLP-1 drugs less likely to develop one?

  • among people who already had a substance use disorder, were those on GLP-1 drugs less likely to experience serious harms, such as hospitalisation, overdose, emergency department visits, or death?

The researchers used a method called “target trial emulation,” which structures an observational study to resemble a randomised controlled trial as closely as possible.

In a randomised controlled trial, participants are randomly assigned to receive either the drug being tested or a comparison treatment. The two groups should be similar in every way except for the treatment they receive. If one group does better, we can be confident the drug caused it.

Observational studies work differently. No matter how carefully researchers try to account for differences such as weight, age and other health conditions, there is always the possibility that some unmeasured factor explains the results.

The target trial emulation design used here is among the best available approaches for observational data, but it cannot eliminate this problem. It can tell us that something is associated with better outcomes; it cannot prove that the drug caused those outcomes.

What did they find?

With that caveat in mind, the results were notable. Among people without a prior substance use disorder, those on GLP-1 drugs were less likely to develop one across every substance category examined:

  • alcohol, an 18% lower risk
  • cannabis, 14% lower
  • cocaine, 20% lower
  • nicotine, 20% lower
  • opioids, 25% lower.

This amounted to roughly 1–6 fewer cases per 1,000 people over three years.

For those who already had a substance use disorder, those prescribed GLP-1 drugs had better outcomes across every measure:

  • 31% fewer emergency department visits related to their substance use disorder
  • 26% fewer hospital admissions
  • a 39% reduction in overdoses
  • a 25% reduction in suicidal thoughts or attempts
  • 50% fewer deaths.

This amounted to around 1–10 fewer events per 1,000 people over three years.

That these patterns held across multiple substances and multiple outcomes makes them harder to dismiss.

But they remain associations, not proof. The ongoing randomised trials will be essential for determining whether GLP-1 drugs genuinely cause these benefits, or whether something else is at work.

But these results might not apply to everyone

The cohort was 90% male with an average age of 65, so findings may not extend to women, younger people, or those without type 2 diabetes.

The group also had significant health complexity. More than half (57%) were current or former smokers, over 40% had high cholesterol, and many had additional conditions including high blood pressure, heart disease and heart failure.

Mental health conditions were also common – more than 18% had post-traumatic stress disorder (PTSD), over 10% had depression and over 10% had anxiety.

We also don’t know whether participants were receiving any treatment for their substance use disorder, which could itself influence outcomes.

The bigger picture

Perhaps the most important takeaway isn’t about GLP-1 drugs at all. Substance use disorders are highly treatable.

Effective, evidence-based medications already exist – naltrexone and acamprosate for alcohol, methadone and buprenorphine for opioids – alongside a wide range of psychological therapies.

These treatments are safe and effective, yet only a small fraction of people who could benefit from them ever receive them. An estimated 3% of people with alcohol use disorder are ever prescribed effective medication.

The biggest barrier isn’t availability: it’s stigma, shame, fear of judgment and discrimination. Society still views addiction as a moral failing rather than a health condition.

For people living with a substance use disorder, this research on GLP-1s is encouraging but the more immediate message is that effective treatments are already available.

Authors: Shalini Arunogiri, Addiction Psychiatrist, Associate Professor, Monash University

Read more https://theconversation.com/glp-1-drugs-like-ozempic-may-lower-the-risk-of-addiction-new-study-277367

The Fire Safety Checklist Every Australian Short-Stay Host Should Run

Picture an Airbnb guest arriving late, tired, in a place they’ve never been. They don’t know where the exits are, which door leads to the garage, or h...

Better Business Photos Without Misleading Customers: An Australian Guide

A timber dining set looks inviting against a sunny deck, with cushions, lanterns and enough chairs for the whole family. But imagine the retailer sell...

Understanding a dental implant Melbourne Treatment Plan

A dental implant Melbourne patients may consider is one option for replacing a missing tooth, but suitability depends on oral health, bone support a...

How 3PL Logistics Australia Supports Faster and More Efficient Supply Chains

Why Has 3PL Logistics Become Important for Growing Businesses?  Gone are the days when supply chains were simpler and in minimal quantity. Now, the...

Common Skin Concerns and Treatment Options Available in Melbourne

Skin concerns can develop gradually or become noticeable following changes in age, lifestyle, sun exposure or hormonal factors. Pigmentation, rednes...

Why a Code-Compliant Home Can Still Feel Uncomfortable

When people build or renovate a home, they usually expect that meeting current building requirements will also produce a comfortable place to live. ...

Breach of Contract in Business: What Are Your Options?

Contracts are essential to business relationships. They establish expectations, allocate responsibilities and provide a framework for delivering goods...

How Pest Control Companies Can Rank for the Problems Customers Search First

Introduction SEO for Pest Control needs to start with the customer’s problem. Most people do not search for pest services in a neat or technical wa...

What Are the Benefits of Renovating an Older Home in Sydney?

Sydney has plenty of character homes, from Federation cottages to mid-century brick homes. Renovating rather than rebuilding can preserve what makes t...

Pool and Deck Design: How to Plan the Perfect Outdoor Living Space for Your Sydney Home

For many Australians, the backyard is where life happens. Summer barbecues, weekend swims and long evenings outdoors are all part of the lifestyle, ...

Is Solar Pool Heating Worth It? What Sydney Homeowners Should Know

There's nothing quite like a backyard pool on a hot Sydney day. But once autumn rolls in, many pools sit unused for months because the water is simp...

Planning a Luxury House Move: A Week-by-Week Timeline for Prestige Sydney Homes

Selling or buying a prestige home is a major milestone. Whether it's a waterfront residence in Birchgrove, a grand Federation home in Haberfield or ...

Downsizing or Upgrading Your Caravan? Here's How to Sell It Without the Hassle

Selling a caravan can feel like a major task, especially when you are unsure about its value, paperwork, or how to find a buyer. Whether you are dow...

The Best Overseas Adventure Holidays for Australians Who Love the Outdoors

Australia offers no shortage of incredible outdoor experiences, but sometimes the best way to satisfy your sense of adventure is to head overseas. A...

Cape Town Wine Shuttle: Winelands Tasting & Tours

Embark on an unforgettable journey through the picturesque Cape Winelands, where world-class wines and breathtaking scenery await. Our Cape Town Win...

Metal Fabrication: Choosing Metal Fabrication Melbourne Services for Custom Projects

What Modern Metal Fabrication Involves From individual components to complete structures, metal fabrication brings together processes such as desig...

Why Giant Rats Tail Grass Keeps Coming Back After Spraying

Giant Rats Tail Grass (GRT) is one of the most frustrating pasture weeds for farmers and lifestyle property owners. You spray an infested area, see th...

When Custom Cardboard Boxes Make Sense for Your Business

Custom cardboard boxes can be useful when a standard carton does not fit a product, packing method or presentation requirement particularly well. A ...